Founding offer · lifetime membership for a single £24, exclusive to our first members · closes 20 June Claim your place →
Global Research Partnerships £24 Lifetime Log inCreate free account

Funded Projects › FP7

ANGIOSCAFF · Angiogenesis-inducing Bioactive and Bioresponsive Scaffolds in Tissue Enginering

FP7Status: CLOSED1 December 200830 November 2012EU funding €11,631,240

Angiogenesis underlies almost all biological processes of morphogenesis, including those in tissue repair and regeneration. Physiological angiogenesis is controlled by a complex interplay between cells and their environment: the extracellular matrix (ECM) provides signaling via numerous ECM adhesion molecules and growth factors bound to ECM polysaccharide components; and cells locally degrade and remodel the ECM to create pores into which angiogenic endothelial cells migrate. This observation, that physiological angiogenesis proceeds in response to solid-phase cues motivates our approach, namely creating bioactive resorbable materials as scaffolds that contain bound molecular signals to induce physiological angiogenesis in situations of tissue repair and regeneration. In some of our scaffold materials, porosity is inherent by virtue of fabrication, and in others porosity is created by cell-associated proteolysis as it is in physiological angiogenesis. All materials will be designed so as to be injectable or implantable into the human body. In some work, the final injectable/implantable material will comprise only materials and bioactive biomolecular signals, and in other cases it will also comprise cells. Thus, the concept of ANGIOSCAFF is to create materials that are bioresponsive (to environmental signals including pH and redox potential, and to cellular signals such as proteases), that are bioactive (by virtue of bound peptide or recombinant protein adhesion ligands and bound and releasable growth factors), and that are capable of carrying cellular therapeutics. To realize ANGIOSCAFF, we have assembled a team comprising both industrial and academic expert groups in biomaterials design and development, experts in the science and application of angiogenesis, in imaging in animal models, and in applications demanding biomaterials-based, angiogenesis-demanding tissue engineering therapies, including repair of bone, skin, cardiac muscle, skeletal muscle and nerve.

Consortium · 33 organisations

coordinator

ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE

CH · €2,267,214

participant

KUROS BIOSURGERY AG

CH · €364,590

participant

BIO-HYOS AB

SE · €353,519

participant

NEWRON SWEDEN AB

SE · €87,600

participant

BAYER INNOVATION GMBH

DE · €1,731

participant

THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE

UK · €383,515

participant

LUDWIG BOLTZMANN GESELLSCHAFT OSTERREICHISCHE VEREINIGUNG ZUR FORDERUNG DER WISSENSCHAFTLICHEN FORSCHUNG

AT · €514,866

participant

BIORIGEN SRL

IT · €327,565

participant

FONDAZIONE CENTRO SAN RAFFAELE DEL MONTE TABOR

IT · €116,763

participant

SMITH & NEPHEW UK LIMITED

UK · €8,089

participant

MILTENYI BIOTEC GMBH

DE · €203,889

participant

DANDO WEISS & COLUCCI LIMITED

UK · €338,566

participant

FUNDACIO INSTITUT DE BIOENGINYERIA DE CATALUNYA

ES · €407,465

participant

UPPSALA UNIVERSITET

SE · €393,629

participant

AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS

ES · €345,124

participant

University of Zurich

CH · €428,406

participant

UNIVERSITAT ZU KOLN

DE · €462,364

participant

FONDAZIONE MULTIMEDICA ONLUS

IT · €259,494

participant

EIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZUERICH

CH · €433,668

participant

JOHANN WOLFGANG GOETHE-UNIVERSITAET FRANKFURT AM MAIN

DE · €364,529

participant

BAXALTA INNOVATIONS GMBH

AT · €34,800

participant

IRCCS OSPEDALE POLICLINICO SAN MARTINO

IT

participant

UNIVERSITAETSKLINIKUM HAMBURG-EPPENDORF

DE · €425,795

participant

THE UNIVERSITY OF NOTTINGHAM

UK · €352,375

participant

INTERCYTEX LTD

UK · €70,418

participant

TECHNION - ISRAEL INSTITUTE OF TECHNOLOGY

IL · €752,067

participant

UNIVERSITY COLLEGE LONDON

€128,063

participant

ISTITUTO NAZIONALE PER LA RICERCA SUL CANCRO

IT · €375,416

participant

LEIBNIZ-INSTITUT FUR POLYMERFORSCHUNG DRESDEN EV

DE · €426,072

participant

UNIVERSITATSSPITAL BASEL

CH · €350,036

participant

UNIVERSITA DEGLI STUDI DI ROMA LA SAPIENZA

IT · €224,985

participant

IFOM-ISTITUTO FONDAZIONE DI ONCOLOGIA MOLECOLARE ETS

IT · €271,520

participant

FONDAZIONE PARCO BIOMEDICO SAN RAFFAELE

IT · €157,108

Research fields

View the official record on CORDIS →

← Find collaborators and more funded projects

Source: CORDIS, Publications Office of the European Union. Global Research Partnerships surfaces open EU research data to help you find collaborators; we are not affiliated with the European Union.